PAPER Johnson FR, DiSantostefano RL, Yang JC, Reed SD, Streffer J, Levitan B

Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms.

Value Health. 2019 Sep;22(9):1063-1069. Epub 2019 Jul 20 PubMed: 31511183

PAPER Vonk JM, Jonkers R, Hubbard HI, Gorno-Tempini ML, Brickman AM, Obler LK

Semantic and lexical features of words dissimilarly affected by non-fluent, logopenic, and semantic primary progressive aphasia.

J Int Neuropsychol Soc. 2019 Nov;25(10):1011-1022. Epub 2019 Sep 12 PubMed: 31511121

PAPER Franzen S, van den Berg E, Goudsmit M, Jurgens CK, van de Wiel L, Kalkisim Y, Uysal-Bozkir Ö, Ayhan Y, Nielsen TR, Papma JM

A Systematic Review of Neuropsychological Tests for the Assessment of Dementia in Non-Western, Low-Educated or Illiterate Populations.

J Int Neuropsychol Soc. 2019 Sep 12;:1-21. PubMed: 31511111

PAPER Choe YM, Byun MS, Yi D, Lee JH, Jeon SY, Sohn BK, Kim YK, Shin SA, Sohn CH, Lee YJ, Lee DY, KBASE Research Group

Sleep experiences during different lifetime periods and in vivo Alzheimer pathologies.

Alzheimers Res Ther. 2019 Sep 12;11(1):79. PubMed: 31511066

PAPER de Wilde A, Reimand J, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, van der Flier WM, Scheltens P, van Berckel BN, Bouwman F, Ossenkoppele R

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.

Alzheimers Res Ther. 2019 Sep 12;11(1):78. PubMed: 31511058

PAPER Mukherjee S, Perumal TM, Daily K, Sieberts SK, Omberg L, Preuss C, Carter GW, Mangravite LM, Logsdon BA

Identifying and ranking potential driver genes of Alzheimer's disease using multiview evidence aggregation.

Bioinformatics. 2019 Jul 15;35(14):i568-i576. PubMed: 31510680

PAPER Du L, Liu K, Zhu L, Yao X, Risacher SL, Guo L, Saykin AJ, Shen L, Alzheimer’s Disease Neuroimaging Initiative

Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort.

Bioinformatics. 2019 Jul 15;35(14):i474-i483. PubMed: 31510645

PAPER Elia CA, Tamborini M, Rasile M, Desiato G, Marchetti S, Swuec P, Mazzitelli S, Clemente F, Anselmo A, Matteoli M, Malosio ML, Coco S

Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer's Disease.

Cells. 2019 Sep 10;8(9) PubMed: 31510042

PAPER Thüne K, Schmitz M, Villar-Piqué A, Altmeppen HC, Schlomm M, Zafar S, Glatzel M, Llorens F, Zerr I

The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers.

Expert Rev Mol Diagn. 2019 Nov;19(11):1007-1018. Epub 2019 Sep 26 PubMed: 31512940

PAPER Sanyal J, Anirudhan A, Banerjee TK, Guha G, Ramakrishnan Veerabathiran, Murugesan R, Ahmed SS, Rao VR

PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson's Disease.

Cell Mol Neurobiol. 2019 Sep 11; PubMed: 31512170

Scott Counts on Tiny Brain Structure Plays Big Role in Memory

COMMENT Our group and others have shown that postmortem variables such as locus coeruleus neuron number, density, and volume are all associated with antemortem performance in multiple cognitive domains, including memory. If you think about the role of forebrain n

End of the BACE Inhibitors? Elenbecestat Trials Halted Amid Safety Concerns

RESEARCH NEWS 2019-09-13 Research News Marking the fall of the only remaining BACE inhibitor currently being tested for AD, Biogen and Eisai announced today the discontinuation of two Phase 3 studies of elenbecestat  in people with mild cognitive impairment and mild AD. The compa

L. Gillen

McDaniel College

PAPER Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, Chesselet MF

Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein.

Neuroscience. 2006 Nov 3;142(4):1245-53. Epub 2006 Aug 23 PubMed: 16934409

PAPER Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF

Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

J Neurosci. 2004 Oct 20;24(42):9434-40. PubMed: 15496679